Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Record year for Biofortuna Contract Services divisionBiofortuna Ltd is pleased to announce a record year of growth for its IVD Contract Services division. This growth has been driven by the expansion of its service portfolio, together with increased demand for its core lyophilisation services.
By: Biofortuna Biofortuna's success stems from its specialist freeze-drying expertise and proprietary cryopreservation technologies, allowing the stabilisation of complete PCR, isothermal amplification and immunoassay reactions into instantly soluble freeze-dried pellets. This lyophilisation technique provides a simple solution for ambient temperature shipping and storage, and offers single-step setup protocols for end users. The success of this approach has led to significant expansion of the company's ISO 13485 accredited and FDA registered services, which now include contract research and development, lyophilisation, air-drying, manufacturing, dispensing and kitting of diagnostic products. Its analytical stabilisation offerings have also been extended, with the addition of Karl-Fischer titration and DSC instrumentation. Over the next year, Biofortuna plans to further expand its customer base by investing in state-of-the- Biofortuna Media Contacts Dr Simon Douglas Chief Executive Officer E: simon.douglas@ End
Account Email Address Disclaimer Report Abuse
|
|